Late malignant transformation of giant cell tumor of bone 41 years after primary surgery. 2012

Masaru Kadowaki, and Soichiro Yamamoto, and Yuji Uchio
Department of Orthopaedic Surgery, Shimane University School of Medicine, Izumo-shi, Shimane, Japan. masaru11@med.shimane-u.ac.jp

Giant cell tumor of bone is an uncommon benign tumor that frequently recurs locally. Spontaneous malignant transformation of conventional giant cell tumor of bone is rare and usually occurs with irradiation.This article describes a case of malignant transformation of a giant cell tumor 41 years after initial curettage and subsequent resection. A 68-year-old man presented with a 6-month history of left hip pain. He had been diagnosed 41 years previously with giant cell tumor in the left femoral neck treated by simple curettage and bone grafting, followed by resection of the femoral head 1 year later for local recurrence. On presentation, radiographs revealed a destructive lesion in the left proximal femur. Incisional biopsy revealed recurrence of giant cell tumor with suspected malignant transformation. The patient underwent en bloc resection of the proximal femur with adequately wide margins and reconstruction of the hip joint with a prosthesis. Pathological findings showed malignant transformation of a giant cell tumor to osteosarcoma and leiomyosarcoma. No recurrence or metastasis developed during 2-year follow-up. Benign local recurrences usually arise in the first 3 postoperative years, whereas malignant transformation tends to take longer than 3 years. To the authors' knowledge, the 41-year interval from primary surgery to diagnosis of malignancy for the current patient is the longest interval reported among cases in which patients received no radiation therapy.

UI MeSH Term Description Entries
D008297 Male Males
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D005266 Femoral Neoplasms New abnormal growth of tissue in the FEMUR. Femoral Neoplasm,Neoplasm, Femoral,Neoplasms, Femoral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D018212 Giant Cell Tumor of Bone A bone tumor composed of cellular spindle-cell stroma containing scattered multinucleated giant cells resembling osteoclasts. The tumors range from benign to frankly malignant lesions. The tumor occurs most frequently in an end of a long tubular bone in young adults. (From Dorland, 27th ed; Stedman, 25th ed)

Related Publications

Masaru Kadowaki, and Soichiro Yamamoto, and Yuji Uchio
January 1990, Bulletin of the Hospital for Joint Diseases Orthopaedic Institute,
Masaru Kadowaki, and Soichiro Yamamoto, and Yuji Uchio
April 2021, JBJS case connector,
Masaru Kadowaki, and Soichiro Yamamoto, and Yuji Uchio
September 1989, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Masaru Kadowaki, and Soichiro Yamamoto, and Yuji Uchio
December 2000, Clinical orthopaedics and related research,
Masaru Kadowaki, and Soichiro Yamamoto, and Yuji Uchio
February 1997, The Journal of bone and joint surgery. American volume,
Masaru Kadowaki, and Soichiro Yamamoto, and Yuji Uchio
January 2001, European radiology,
Masaru Kadowaki, and Soichiro Yamamoto, and Yuji Uchio
February 2001, Skeletal radiology,
Masaru Kadowaki, and Soichiro Yamamoto, and Yuji Uchio
March 1974, Surgical neurology,
Masaru Kadowaki, and Soichiro Yamamoto, and Yuji Uchio
April 2021, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
Masaru Kadowaki, and Soichiro Yamamoto, and Yuji Uchio
January 2011, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association,
Copied contents to your clipboard!